| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.065 | 0.1 |